Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I was shocked to see that RGIN is still filing 10Qs and 10-Ks. They've been radio silent for three years now. Why keep filing if there is no hope in moving PermaDerm forward?
GM all. Please do break it down, would be greatly appreciated!
Great, thank you.
Please share on Twitter as well.
We need an update with a bit more detail, and a realistic timeline. If it's June, fine, but let that be known.
I'd be thrilled to see an SEC alert this evening that CBBT has uploaded on or more past due filings, followed by a PR next week.
Which of the conditions listed in the link below would have triggered the change in status?
https://www.law.cornell.edu/cfr/text/17/240.3a51-1
Interesting, thanks for sharing.
Any idea what the caller is referring to when he says "CBBT is no longer listed as a penny stock"?? Nothing has changed on otcmarkets.com, they still have the STOP sign, which is nothing new. But there is no Caveat Emptor indication.
OK, thanks...phew! If it were the latter, that could be concerning.
Want to make sure I'm reading this correctly. Does Alan's statement in bold refer to his statement in red, or his statement in italics?
I see the significant amount of emails concerned with the market action coming in today.
Mr Clemons was in Boise yesterday meeting with the entire management team of PKG. Not sure why this is happening as nothing has changed since last week and things are moving forward per my last communication with the company.
Good to know. I guess that's the $70 million in funding the new CEO was referring to on his LinkedIn post. They'll need it for dozens of job openings they've got!
I agree with this, I think this explains 75% of the dip in price. But, I do think the repeated delays in finalizing the acquisition can be assigned the remaining 25% of the blame.
is VNTH in any way connected to this study, or the researchers involved?
Toward a disease-sniffing device that rivals a dog's nose
https://phys.org/news/2021-02-disease-sniffing-device-rivals-dog-nose.html
Now, a team of researchers at MIT and other institutions has come up with a system that can detect the chemical and microbial content of an air sample with even greater sensitivity than a dog's nose. They coupled this to a machine-learning process that can identify the distinctive characteristics of the disease-bearing samples.
The findings, which the researchers say could someday lead to an automated odor-detection system small enough to be incorporated into a cellphone, are being published today in the journal PLoS ONE, in a paper by Clare Guest of Medical Detection Dogs in the U.K., Research Scientist Andreas Mershin of MIT, and 18 others at Johns Hopkins University, the Prostate Cancer Foundation, and several other universities and organizations.
..........
Mershin and the team over the last few years have developed, and continued to improve on, a miniaturized detector system that incorporates mammalian olfactory receptors stabilized to act as sensors, whose data streams can be handled in real-time by a typical smartphone's capabilities. He envisions a day when every phone will have a scent detector built in, just as cameras are now ubiquitous in phones. Such detectors, equipped with advanced algorithms developed through machine learning, could potentially pick up early signs of disease far sooner than typical screening regimes, he says—and could even warn of smoke or a gas leak as well.
In the latest tests, the team tested 50 samples of urine from confirmed cases of prostate cancer and controls known to be free of the disease, using both dogs trained and handled by Medical Detection Dogs in the U.K. and the miniaturized detection system. They then applied a machine-learning program to tease out any similarities and differences between the samples that could help the sensor-based system to identify the disease. In testing the same samples, the artificial system was able to match the success rates of the dogs, with both methods scoring more than 70 percent.
Wrong, it was first announced back in August 2020. That's six months, not a year+.
I'm assuming/hoping that the 700K of Cerebain's money invested into PKG thus far, refers to consulting fees paid to NMS Consulting and the attorneys involved.
It would go a long way if Eric's social media updates were to contain at least some specificity/detail.
It does seem that way.
Thanks, doesn't get much clearer than that.
PKG had posted about his passing on LinkedIn, as well, IIRC.
For me, repeated missed deadlines cast some doubt. Either they've opened a can of worms far bigger than they envisioned, or some unknown has added complexity to the transaction. With all of the smart people working on this (NMS Consulting, attorneys, etc.), how is it that the assumed deadline has been kicked down the road so many times?
COVID has been with us for a year, so that ought to have been factored in. Holidays are over. Just a bit of a head scratcher.
Grateful, sure. But we absolutely DID NEED the update.
Agreed! Maybe it's the cursed scroll from Evil Dead, and by reading it, they unleashed a great evil upon the auditors, which now requires the assistance of an exorcist.
LOL no worries. Now I feel old
At this point, why not just issue a formal press release and state that acquisition will be finalized by end of the 2nd quarter? Sure, the share price will dip as weak hands sell, but it also provides some certainty. Unless I'm way off in believing that this should absolutely be complete by then.
What do you mean by 'a dank update'?
Completely agree with this. Communication is crucial.
ENZC is also down big today, too. I think the market is spooked, mainly due to the SEC hold on COUV shares, which has in turn freaked out countless novice investors.
The fact that CBBT has been late several times on projected dates, isn't helping matters.
I think something is trying to be solved for financials or they are waiting for FDA approval to be dropped same time as finalization of the acquisition.
That is a godawful idea. Why not get things done step by step, and release news to confirm each of the following milestones, as they are completed?
1. Up to date financial filings
2. Confirmation of PKG acquisition
3. Device trial progress, or FDA approval
Now more than ever, they need to get caught up on filings. On the plus side, Clear Mask is legit, so it's not like the SEC can say that Cerebain was pumping the stock price with that.
While weakness in the overall economy impacts all equities, directly or indirectly, I do think that the SEC's recent crackdown on OTC and Pink stocks is finally spooking the OTC market. DECN is another one that got taken out recently.
All the more reason why CBBT needs to get caught up on financial filings asap. Acquisition can come later, but get those filings done.
I was just going to post that. I think it's very likely that that is the case. OTC just got spooked.
https://www.sec.gov/litigation/suspensions/2021/34-91093.pdf
Please do share (those trades).
Over $15 million in shares traded today!
Congrats to all. Still holding; up to date filings, confirmation of acquisition, along with updated business plans should give this a significant boost.
52 Open Positions!
https://www.kloudgaze.com/career/
While there are ten distinct roles for which they are hiring, there are numerous openings per role. Senior Full Stack Java Developer alone has 25 openings available. The aforementioned $70 million dollar round of funding makes a lot more sense now.
CBBT will become the Saturn to ENZC's Jupiter.
The CEO's background/experience and industry contacts, coupled with the potential of the software, is the value here.
With any luck, we get answers to at least some of your questions, when the capital raise is finalized/announced.